• Brazil has approved the use of the Pfizer COVID-19 vaccine for children aged 3 to 5 years old.
  • The decision was made by the country's health regulatory agency, Anvisa, following positive evaluations of safety and efficacy.
  • This approval makes Brazil one of the first countries in Latin America to authorize vaccination for this younger age group.
  • The vaccination campaign for young children is expected to begin soon, aiming to protect this vulnerable population.
  • Health authorities emphasize the importance of vaccinating children to curb the spread of COVID-19 and prevent severe cases.